Abida Zafar, MD
Nephrology · Port Huron, MINPI 1265434898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Nxstage Medical, Inc. at 53.3% of the total. That places this record below the midpoint for nephrology clinicians in MI, where the typical reported total is $606.
Across 5 payments — averaging $57.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nxstage Medical, Inc.$153
- Vertex$94
- Fresenius USA Marketing, Inc.$20
- Aurinia Pharma U.S., Inc.$20
Across 79 payments — averaging $970.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Akebia Therapeutics Inc$72K
- AstraZeneca$5K
What the payments were for
- Food & beverage$26793%
- Education$207%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nxstage Medical, Inc. | 2 | $153 |
| Vertex | 1 | $94 |
| Fresenius USA Marketing, Inc. | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$287 in reported general payments places this provider in the 35th percentile of 325 nephrology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 17 | $21,184 |
| Lanthanum Carbonate | 11 | $17,121 |
| Sevelamer Carbonate | 26 | $7,705 |
| Calcium Acetate | 39 | $3,567 |
| Calcitriol | 32 | $1,415 |
| Midodrine Hcl | 13 | $578 |
| Furosemide | 76 | $533 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 12 | $521 |
| Metoprolol Succinate | 28 | $521 |
| Carvedilol | 40 | $415 |
| Minoxidil | 12 | $317 |
| Amlodipine Besylate | 35 | $248 |
| Potassium Chloride | 21 | $227 |
| Allopurinol | 27 | $213 |
| Metoprolol Tartrate | 33 | $179 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Port Huron
- Alexander YevzlinAnn Arbor$1.1M
- Muwaffaq SalamehBay City$164K
- Laura MarianiAnn Arbor$150K
- Crystal Gardner-MartinLivonia$140K
- Katherine KwonSaint Joseph$111K
- Anatole BesarabDetroit$102K
- Richard CrossSaint Clair Shores$96K
- Kausik UmanathDetroit$85K
- Joel TopfRoseville$79K
- Matthias KretzlerAnn Arbor$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.